{"entity":{"id":"valdas-peceliunas","kind":"person","name":"Valdas Pečeliūnas","aka":[],"tldr":"Director who leads the National Cancer Institute in Vilnius, Lithuania's national specialist cancer treatment and research institute.","summary":"Valdas Pečeliūnas leads the National Cancer Institute (Nacionalinis vėžio institutas, NVI) in Vilnius as its Director. The institute is a non-profit public legal entity that combines specialist cancer treatment with cancer research, and its scientific work is overseen by an eleven-member Scientific Council elected for five-year terms. The Lithuanian Wikipedia article on the institute names him as the current director; the institute's own website describes its structure and administration without publishing leadership names.","asOf":"2026-09-10","links":[{"label":"Source: Lithuanian Wikipedia article naming the director","url":"https://lt.wikipedia.org/wiki/Nacionalinis_vėžio_institutas"},{"label":"Institute about page","url":"https://nvi.lt/apie-mus/"}],"tags":["leadership","research-institute","hospital-management"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["nci-vilnius"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["lancet-haematology"],"dependsOn":[],"notes":[],"role":"Director, National Cancer Institute (Nacionalinis vėžio institutas), Vilnius","institutionId":"nci-vilnius","specialisms":["Oncology","Cancer institute management","Cancer research"],"profiles":[{"label":"Wikipedia (Lithuanian) article on the institute","url":"https://lt.wikipedia.org/wiki/Nacionalinis_vėžio_institutas"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Peceliunas+V%5BAuthor%5D"}],"papers":[{"title":"Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study","journal":"The Lancet Haematology","year":2021,"doi":"10.1016/s2352-3026(21)00169-1"},{"title":"Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood","journal":"International Journal of Laboratory Hematology","year":2020,"doi":"10.1111/ijlh.13387"},{"title":"Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes","journal":"Medicina","year":2019,"doi":"10.3390/medicina55060238"}]},"route":"/people/valdas-peceliunas/","neighbours":{"institution":[{"id":"nci-vilnius","kind":"institution","name":"National Cancer Institute, Lithuania","route":"/institutions/nci-vilnius/"}],"journal":[{"id":"lancet-haematology","kind":"journal","name":"The Lancet Haematology","route":"/journals/lancet-haematology/"}]}}